Witjes JA - Search Results

1

Site-specific familial aggregation of prostate cancer.

Verhage BA, Aben KK, Witjes JA, Straatman H, Schalken JA, Kiemeney LA. Verhage BA, et al. Among authors: witjes ja. Int J Cancer. 2004 Apr 20;109(4):611-7. doi: 10.1002/ijc.20015. Int J Cancer. 2004. PMID: 14991584 Free article. Review.

2

Prognostic factors in superficial bladder cancer. A review.

Witjes JA, Kiemeney LA, Oosterhof GO, Debruyne FM. Witjes JA, et al. Eur Urol. 1992;21(2):89-97. doi: 10.1159/000474811. Eur Urol. 1992. PMID: 1499622 Review. No abstract available.

3

Bladder cancer mortality in The Netherlands, 1955-1988.

Kiemeney LA, Verbeek AL, Nelemans PJ, Witjes JA, Straatman H. Kiemeney LA, et al. Among authors: witjes ja. Br J Urol. 1992 Jul;70(1):46-52. doi: 10.1111/j.1464-410x.1992.tb15663.x. Br J Urol. 1992. PMID: 1638374

4

Expression of markers for transitional cell carcinoma in normal bladder mucosa of patients with bladder cancer.

Witjes JA, Umbas R, Debruyne FM, Schalken JA. Witjes JA, et al. J Urol. 1995 Dec;154(6):2185-9. J Urol. 1995. PMID: 7500486

5

Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer.

Kiemeney LA, Witjes JA, Heijbroek RP, Debruyne FM, Verbeek AL. Kiemeney LA, et al. Among authors: witjes ja. Eur J Cancer. 1994;30A(11):1621-5. doi: 10.1016/0959-8049(94)e0133-o. Eur J Cancer. 1994. PMID: 7833133

6

Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological Group.

Kiemeney LA, Witjes JA, Heijbroek RP, Koper NP, Verbeek AL, Debruyne FM. Kiemeney LA, et al. Among authors: witjes ja. Br J Urol. 1994 Feb;73(2):164-71. doi: 10.1111/j.1464-410x.1994.tb07486.x. Br J Urol. 1994. PMID: 8131019

7

The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Members of the Dutch South East Cooperative Urological Group.

Witjes JA, Kiemeney LA, Schaafsma HE, Debruyn FM. Witjes JA, et al. Br J Urol. 1994 Feb;73(2):172-6. doi: 10.1111/j.1464-410x.1994.tb07487.x. Br J Urol. 1994. PMID: 8131020 Clinical Trial.

8

The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group.

Kiemeney LA, Witjes JA, Verbeek AL, Heijbroek RP, Debruyne FM. Kiemeney LA, et al. Among authors: witjes ja. Br J Cancer. 1993 Apr;67(4):806-12. doi: 10.1038/bjc.1993.147. Br J Cancer. 1993. PMID: 8471440 Free PMC article.

9

Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.

Kiemeney LA, Witjes JA, Heijbroek RP, Verbeek AL, Debruyne FM. Kiemeney LA, et al. Among authors: witjes ja. J Urol. 1993 Jul;150(1):60-4. doi: 10.1016/s0022-5347(17)35397-1. J Urol. 1993. PMID: 8510276

10

Comparison of P53 protein overexpression with P53 mutation in bladder cancer: clinical and biologic aspects.

Vet JA, Bringuier PP, Schaafsma HE, Witjes JA, Debruyne FM, Schalken JA. Vet JA, et al. Among authors: witjes ja. Lab Invest. 1995 Dec;73(6):837-43. Lab Invest. 1995. PMID: 8558845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

507 results

Search Page